{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/05/07/3289913/0/en/ArriVent-Announces-IND-Clearance-for-Novel-Tetravalent-MUC16-NaPi2b-Targeting-ADC-ARR-002-with-Initial-Focus-in-Ovarian-and-Endometrial-Cancers.html", "message": "News view counter 709737 successfully enlarged"}